Alembic Pharmaceuticals has informed that the Company's joint venture, Aleor Dermaceuticals has received US Food and Drug Administration (USFDA) Final Approval for Metronidazole Gel USP, 1%. Also enclosed the press release.
The above information is a part of company’s filings submitted to BSE.